# Title

 Food and Drugs. PART 821â€”MEDICAL DEVICE TRACKING REQUIREMENTS


# ID

 CFR-2018-title21-vol8.Pt. 821


# Structured Analysis Summary

| Type        | Values                                                                               |
|:------------|:-------------------------------------------------------------------------------------|
| Constraints | ['before', 'more than', 'within', 'less than', 'after', 'at least', 'prior to']      |
| Duration    | ['6.0 month', '1.0 year', '3.0 year', '90.0 day']                                    |
| Condition   | ['until', 'unless not', 'unless', 'subject to', 'when', 'if']                        |
| Entities    | ['United States', 'Scope', 'Availability', 'Such', 'Food', 'Modification', 'Unique'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                         |
|:--------------|:----------------------------------------------------------------------------------------------------------------|
| more than     | to be implanted in the human body for more than 1 year; or the device is a life-sustaining                      |
| within        | person who causes such failure, misbrands the device within the meaning of section 502(t)(2) of the act         |
| within        | person who causes such failure, misbrands the device within the meaning of section 502(t)(2) of the act         |
| more than     | to be implanted in the human body for more than 1 year means a device that is intended                          |
| more than     | to be implanted in the human body for more than 1 year means a device that is intended                          |
| more than     | life-sustaining or life-supporting device intended for use by more than one patient over the useful life of the |
| within        | of the device: (i) The lot or batch within which a device was manufactured; (ii) The serial                     |
| within        | class II or class III device that fits within  one of the three criteria                                        |
| within        | class II or class III device that fits within  one of the three criteria                                        |
| within        | by order under section 518(e) of the act, within 3 working days of a request from FDA,                          |
| prior to      | 3 working days of a request from FDA, prior to the distribution of a tracked device to a                        |
| within        | by order under section 518(e) of the act, within 3 working days of a request from FDA,                          |
| after         | single patient over the life of the device, after distribution to or implantation in a patient: (i)             |
| within        | by order under section 518(e) of the act, within 10 working days of a request from FDA                          |
| more than     | tracked devices that are intended for use by more than one patient, after the distribution of the device        |
| after         | intended for use by more than one patient, after the distribution of the device to the multiple                 |
| less than     | each device product subject to tracking, at not less than 6-month intervals for the first 3 years of            |
| at least      | for the first 3 years of distribution and at least  once a year thereafter.                                     |
| before        | distributor, multiple distributor, or final distributor in question before  notifying FDA.                      |
| within        | requirement of paragraph (c)(1) of this section shall, within 5 working days of a request from the              |
| within        | requirement of paragraph (c)(1) of this section shall, within 5 working days of a request from the              |
| within        | a centralized point for each manufacturer or distributor within  the United States.                             |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1.0 year   | (a) The regulations in this part implement section 519(e) of the Federal Food, Drug, and Cosmetic Act (the act), which provides that the Food and Drug Administration may require a manufacturer to adopt a method of tracking a class II or class III device, if the device meets one of the following three criteria and FDA issues an order to the manufacturer: the failure of the device would be reasonably likely to have serious adverse health consequences; or the device is intended to be implanted in the human body for more than 1 year; or the device is a life-sustaining or life-supporting device used outside a device user facility. |
| 90.0 day   | (b) A request for an exemption or variance shall be submitted in the form of a petition under &#167;&#8201;10.30 of this chapter and shall comply with the requirements set out therein, except that a response shall be issued in 90 days.                                                                                                                                                                                                                                                                                                                                                                                                               |
| 1.0 year   | (f) Device intended to be implanted in the human body for more than 1 year means a device that is intended to be placed into a surgically or naturally formed cavity of the human body for more than 1 year to continuously assist, restore, or replace the function of an organ system or structure of the human body throughout the useful life of the device.                                                                                                                                                                                                                                                                                          |
| 1.0 year   | (f) Device intended to be implanted in the human body for more than 1 year means a device that is intended to be placed into a surgically or naturally formed cavity of the human body for more than 1 year to continuously assist, restore, or replace the function of an organ system or structure of the human body throughout the useful life of the device.                                                                                                                                                                                                                                                                                          |
| 1.0 year   | The term does not include a device that is intended and used only for temporary purposes or that is intended for explantation in 1 year or less.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 6.0 month  | Modification and changes included under this requirement include modifications to the data (including termination of tracking), the data format, the recording system, and the file maintenance procedures system; and                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|            |               (3) A quality assurance program that includes an audit procedure to be run for each device product subject to tracking, at not less than 6-month intervals for the first 3 years of distribution and at least once a year thereafter.                                                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 year   | Modification and changes included under this requirement include modifications to the data (including termination of tracking), the data format, the recording system, and the file maintenance procedures system; and                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|            |               (3) A quality assurance program that includes an audit procedure to be run for each device product subject to tracking, at not less than 6-month intervals for the first 3 years of distribution and at least once a year thereafter.                                                                                                                                                                                                                                                                                                                                                                                                       |


## Condition

| Condition   | Context                                                                                                                       |
|:------------|:------------------------------------------------------------------------------------------------------------------------------|
| if          | tracking a class II or class III device, if the device meets one of the following three                                       |
| subject to  | with this part rests with manufacturers who are subject to tracking orders, and that responsibility cannot be altered,        |
| subject to  | distributor, or multiple distributor, who distributes a device subject to tracking, who fails to comply with any applicable   |
| subject to  | (d) Any person  subject to this part who permanently discontinues doing business is                                           |
| if          | However,  if a person ceases distribution of a tracked device                                                                 |
| unless      | to be responsible for compliance with this part unless another person, affirmatively and in writing, assumes responsibility   |
| if          | Further,  if a person subject to this part goes out                                                                           |
| subject to  | Further, if a person  subject to this part goes out of business completely, but                                               |
| until       | (c) An exemption or variance is not effective  until the Director, Office of Compliance, CDRH, approves the                   |
| subject to  | initial distributor of an imported device who is subject to  a tracking order.                                                |
| subject to  | user facilities and, therefore, devices used therein are subject to tracking if they otherwise satisfy the statutory and      |
| if          | therefore, devices used therein are subject to tracking if  they otherwise satisfy the statutory and regulatory criteria.     |
| when        | that identifies one or more of the following when included on the label of the device: (i)                                    |
| subject to  | Devices  subject to  tracking.                                                                                                |
| if          | track that device in accordance with this part, if  FDA issues a tracking order to that manufacturer.                         |
| when        | the order, the sponsor must track the device. when                                                                            |
| unless not  | (if available) of the patient receiving the device, unless not released by the patient under &#167;&#8201;821.55(a); (iv) The |
| if          | use by a single patient over the l if e of the device, after distribution to or                                               |
| if          | use by a single patient over the l if e of the device, after distribution to or                                               |
| unless not  | (if available) of the patient using the device, unless not released by the patient under &#167;&#8201;821.55(a); (v) The      |
| if          | the multiple distributor: (i) The unique device ident if ier (UDI), lot number, batch number, model number,                   |
| when        | of the prescribing physician; and (viii) If and when applicable, the date the device was returned to                          |
| when        | procedures, which shall include a procedure for recording when data which is required under this part is                      |
| subject to  | procedure to be run for each device product subject to tracking, at not less than 6-month intervals for                       |
| when        | to comply with the requirements of this part. when                                                                            |
| if          | or multiple distributor; (2) The unique device ident if ier (UDI), lot number, batch number, model number,                    |
| when        | whom the device was received; (5) If and when applicable, the date the device was explanted, the                              |
| unless not  | (if available) of the patient receiving the device, unless not released by the patient under &#167;&#8201;821.55(a); (4) The  |
| if          | the final distributor, (2) The unique device ident if ier (UDI), lot number, batch number, model number,                      |
| when        | retired from use, or otherwise permanently disposed of. when                                                                  |
| unless not  | the device; (iii) The location of the device, unless not released by the patient under &#167;&#8201;821.55(a); (iv) The       |
| if          | (i) The unique device ident if ier (UDI), lot number, batch number, model number,                                             |
| when        | retired from use or otherwise permanently disposed of. when                                                                   |
| subject to  | act, any person who is a multiple distributor subject to the recordkeeping requirement of paragraph (c)(1) of this            |
| subject to  | (a) Any patient receiving a device  subject to tracking requirements under this part may refuse to                            |
| subject to  | be disclosed to a manufacturer or other person subject to this part or to a physician when the                                |
| when        | subject to this part or to a physician when the health or safety of the patient requires                                      |
| if          | For example, a record may be retired  if the person maintaining the record becomes aware of                                   |


## Entities

| Entities      | Context                                                                        |
|:--------------|:-------------------------------------------------------------------------------|
| Food          | Food  and Drugs.                                                               |
| Scope         | Scope .                                                                        |
| Unique        | (o)  Unique device identifier (UDI) means an identifier that adequately        |
| United States | all information required under this part in the United States .                |
| Modification  | Modification and changes included under this requirement include modifications |
| Availability  | Availability .                                                                 |
| United States | point for each manufacturer or distributor within the United States .          |
| Such          | Such notification will be pursuant to agreement that the                       |
| Such          | Such notification does not constitute public disclosure and will               |


